Uma Goyal, MD, awarded 2015-16 Better Than Ever research grant
Uma Goyal, MD, will receive a $25,500 research grant from the University of Arizona Cancer Center’s Better Than Ever (BTE) program to study improved techniques for specialized brachytherapy treatments for cervical cancer patients.
Arizona Public Media to air follow-up story on UACC patient
In March, Arizona Public Media aired an original documentary, "Winning By Living, One Cancer Story,” that chronicled the unique pancreatic cancer battle of Michelle Kirlew. In June, AZPM checks back in with the Kirlews.
Chad Adams, MPH, joins UACC as Assistant Director of Cancer Clinical Research
Please welcome Chad Adams, MPH, as he joins the University of Arizona Cancer Center as the Assistant Director of Cancer Clinical Research.
Laurence Hurley, PhD, named 13th annual Sydney E. Salmon, MD, Distinguished Investigator
Laurence Hurley, PhD, has been named the winner of the 13th annual Sydney E. Salmon, MD, Distinguished Investigator Award.
UACC researchers discover potential cancer-fighting properties in cinnamon
Cancer researchers are looking into a possible new tool in the fight against colon cancer: cinnamon.
ASHLine ready to help Phoenix 'Kick Butts'
The Arizona Smokers’ HelpLine (ASHLine) has been helping people quit tobacco since 1995. Events during Phoenix Kicks Butts Week are designed to encourage smokers to quit and lead healthier lives.
UA Cancer Center among founding members of the Academic Breast Cancer Consortium
The consortium includes National Cancer Institute-designated cancer centers, and prominent cancer institutes and research organizations.
UACC and BIO5 researcher awarded $1.59 million NCI grant to study drug resistance in lymphoma tumor treatment
Jonathan H. Schatz, MD, was recently awarded a 5-year, $1.59 million grant from the National Cancer Institute (NCI) to study ways to effectively combat drug resistance when treating lymphoma — a study that may have wide-ranging impact when it comes to treating a variety of cancers.
UA-discovered drug for skin disease approved for patients in Europe
A synthetic hormone developed by UA faculty that has been shown to offer relief for a rare skin disease has been approved for patients in Europe.